Rua Life Sciences PLC (LON:RUA)
18.10p+1.97%
Spriggl Score: Weak— sign in to explore; full breakdown with Premium
Last 30 trading days
Spriggl AI Verdict
“Breakeven CDMO growth accelerates while spun-out heart valve business removes cash burn and balance sheet risk.”
Sign up free to read the full investment thesis, bull case, bear case and what to watch.
About Rua Life Sciences PLC
RUA Life Sciences plc, together with its subsidiaries, develops medical devices in Europe, North America, the Middle East, the Asia Pacific, and Africa. It operates through four segments: Biomaterials, Contract Manufacture, Vascular, and Structural Heart. The company acts as the …
- Sector:
- Healthcare
- Industry:
- Medical Devices
- Market Cap:
- £11.8M
Recent dividends
No recent dividends recorded.
Get the full Spriggl analysis — free
A free Spriggl account gets you the screener, a watchlist, AI verdicts and a free full report every day — across Rua Life Sciences PLC and 1,500+ UK and US stocks. The full score breakdown and AI analysis come with Premium.
Start free